1.IHH Singapore Partners Insurers to Champion Colorectal Health
IHH Healthcare Singapore collaborates with leading insurers to promote colorectal health and provide accessible healthcare solutions.
In support of colorectal cancer awareness month, IHH Healthcare Singapore has teamed up with insurer partners -AIA, Income, and Singlife - to provide their customers with packages for selected medical procedures at our four hospitals: Gleneagles Hospital, Mount Elizabeth Hospital, Mount Elizabeth Novena Hospital and Parkway East Hospital.
Formalised during a signing ceremony at Mount Elizabeth Hospital on 17 March 2025, this meaningful collaboration highlights our joint commitment to delivering quality, accessible, and sustainable healthcare, while also raising vital awareness about colorectal health.
Working closely with our valued insurers and medical practitioners, we remain dedicated to strengthening the healthcare ecosystem, improving patient experiences, and uplifting the well-being of our communities.
2.Advancing Treatment for Pulmonary Arterial Hypertension: An Approach with Sotatercept
A development in Pulmonary Arterial Hypertension (PAH) treatment took place at Mount Elizabeth Hospital, Singapore, where a patient received Sotatercept — a therapy that offers additional possibilities for managing this complex condition. This reflects ongoing progress in cardiology and pulmonary hypertension care.
PAH is a progressive disease characterised by the narrowing of blood vessels in the lungs, making it increasingly difficult for the heart to pump blood. Diagnosis is key, as pulmonary hypertension comprises five major types, each requiring a distinct treatment approach. Conventional PAH therapies, such as vasodilators, work by relaxing blood vessels for circulation. Sotatercept, however, functions by restoring the balance of proteins that regulate blood vessel growth and repair. This mechanism may help address vessel thickening and stiffness, supporting long-term management beyond symptom relief.
Dr Edgar Tay and Dr Abdul Razakjr Bin Omar, cardiologists at Mount Elizabeth Hospital, recently shared the journey of a 49-year-old female patient who had been living with PAH for over a decade. In recent months, her symptoms worsened, limiting treatment options and affecting her daily activities. Following the administration of Sotatercept, she experienced measurable benefits, including increased oxygen levels, reduced breathlessness, and more tolerance for travel.
With ongoing developments in cardiology, medical specialists continue to explore treatment approaches for complex cardiovascular conditions. The introduction of Sotatercept provides another option in PAH management, supporting efforts for patient care and quality of life.
